MedQuist Inc. (MEDQ) Dividend Summary

MedQuist, Inc. is the leading national provider of medical transcriptionservices, a key component in the provision of healthcare services. Through their transcriptionists, proprietary software, sophisticated digital dictation equipment and ability to interface with healthcare providers' computer systems, they provide customized solutions to shorten our customers' billing cycles and reduce their overhead and other administrative costs.

Last update 11/09/2010


Dividend Yield Summary

  2009 2010 2011 2012 2013 2014
Dividends $0 $0 $0 $0 $0 $0
Price $6.99 $0 $0 $0 $0 $0
Yield 0 % 0 % 0 % 0 % 0 % 0 %

Earnings Information

Next Report Date 12/31/1969
Estimated EPS (year) $0.00
Estimated EPS (quarter) $0.00
Estimated EPS Growth 0.00%
Payout Ratio 0.00%
Payout change vs. 5 year average 0.00%

Dividend/Split History

Date Amount Per Share/Split Ratio Type
2009-09-15 $1.33000 Dividend
2008-08-04 $2.75000 Dividend

Company Profile

MedQuist, Inc. is the leading national provider of medical transcriptionservices, a key component in the provision of healthcare services. Through their transcriptionists, proprietary software, sophisticated digital dictation equipment and ability to interface with healthcare providers' computer systems, they provide customized solutions to shorten our customers' billing cycles and reduce their overhead and other administrative costs.


MEDQUIST INC
1000 Bishops Gate Blvd
Suite 300
Mount Laurel, NJ 08054-4632, USA
Phone: 856-206-4000
Fax: 856-206-4020
Web: www.medquist.com
Email:

Key Information

Sector: Business Services
Industry: BUSINESS SERVICES
Fiscal Year End: December
Next Reported Fiscal Year: 2008
Last Reported Quarter: 3/31/2009

Management

Presi.; C.E.O. Howard S. Hoffmann
Sr. V.P.; C.F.O. Kathleen E. Donovan
Non-Exec. Chmn. Stephen H. Rusckowski
V.P.; Contrl.; Princ. Acctg. Off. James Brennan
Dir. Brian O���donoghue

Competitors

SIC Code: 7374
Ticker Company Name
ACN ACCENTURE PLC
MAN MANPOWER INC WI
HTZ HERTZ GLBL HLDG
V VISA INC-A
CAR AVIS BUDGET GRP
MA MASTERCARD INC
KELYB KELLY SVCS B

MedQuist Inc. MEDQ (NSDQ) Financial Ratios

 P/E
Current FY Estimate 0.00
Trailing 12 Months 9.20
PEG Ratio 0.00
 EPS Growth
vs. Previous Year 275.00%
vs. Previous Quarter -67.69%
 Sales Growth
vs. Previous Year -6.04%
vs. Previous Quarter -1.87%
 Price Ratios
Price/Book 1.76
Price/Cash Flow 4.96
Price/Sales 0.83
 ROE
03/31/2009 17.01
12/31/2008 14.05
09/30/2008 6.60
 ROA
03/31/2009 11.90
12/31/2008 10.17
09/30/2008 4.86
 Current Ratio
03/31/2009 1.92
12/31/2008 1.87
09/30/2008 1.67
 Quick Ratio
03/31/2009 1.92
12/31/2008 1.87
09/30/2008 1.67
 Operating Margin
03/31/2009 8.58
12/31/2008 8.75
09/30/2008 4.88
 Net Margin
03/31/2009 -18.46
12/31/2008 -17.86
09/30/2008 -21.05
 Pre-Tax Margin
03/31/2009 -23.86
12/31/2008 -23.06
09/30/2008 -26.10
 Book Value
03/31/2009 3.96
12/31/2008 3.91
09/30/2008 3.74
 Inventory Turnover
03/31/2009 0.00
12/31/2008 0.00
09/30/2008 0.00
 Debt-to-Equity
03/31/2009 0.00
12/31/2008 0.00
09/30/2008 0.00
 Debt-to-Capital
03/31/2009 0.00
12/31/2008 0.00
09/30/2008 0.00

Quick Quote

Updated as of N/A
Last Trade: 0.00
Trade Time: N/A
Change: N/A
Open: N/A
High: N/A
Low: N/A
Volume: 0


Security Details

Exchange NSDQ
CUSIP
Split Date 06/16/1998
Split Factor 2
Shares outstanding 37.56
Beta 0.77


Detailed Quote as of 09/10/2009

Price $6.99
52 Week High $9.19
52 Week Low $1.65
Price Change (4 weeks) $-13.60
Price Change (12 weeks) $38.14
Price Change (YTD) $240.98
Price Change (4 weeks) vs. S&P $-16.21
Price Change (12 weeks) vs. S&P $22.86
Price Change (YTD) vs. S&P $203.45
Average Daily Volume (20 Days) 69,747
Market Capitalization $262.52

Price History

Earning Announcement

Last Confirmation Date 2010-08-18
Next Earnings Announcement Date 2010-11-09
Earnings Quarter Q3
Announcement Status Unconfirmed

Last Dividend Payout

Announcement Date 2009-09-02
Record Date 2009-09-09
Pay Date 2009-09-15
Amount Per Share $1.33
What other features would you like to see on this site? Please send us your comments:

NOTE: DividendInformation.com cannot guarantee the accuracy of the data provided. Please consult your broker before making any investment decisions.